TrialArthritis research & therapy2019

Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study.

Eleni Kampylafka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.